As the push for legalization domestically and abroad grows, the cannabis industry continues to garner significant attention from investors, manufacturers and researchers.¹

Combined U.S. medical and recreational cannabis sales are expected to reach $33B by the end of 2022, driven by the opening of new adult usage markets.²

Recently, flower market share has declined in both the U.S. and Canada.³ Beverages and pre-rolled joints saw the most robust YoY growth rates in the United States, while tincture and sublingual products in Canada, released in late 2020 with other “cannabis 2.0” products, saw an unprecedented 3000% growth YoY.³

 

This edition covers:

+ Legislation

+ 2H Outlook

+ Major Claims in the Sector

+ Guidance

 

1The Future of the Marijuana Industry in America (investopedia.com)
2Projected US legal medical and recreational cannabis market size (mjbizdaily.com)
3The Top Cannabis Industry Trends To Watch For 2022 (forbes.com)